48 related articles for article (PubMed ID: 18510707)
1. Tumour microenvironment in pheochromocytoma and paraganglioma.
Martinelli S; Amore F; Canu L; Maggi M; Rapizzi E
Front Endocrinol (Lausanne); 2023; 14():1137456. PubMed ID: 37033265
[TBL] [Abstract][Full Text] [Related]
2. Novel Germline
Provenzano A; Chetta M; De Filpo G; Cantini G; La Barbera A; Nesi G; Santi R; Martinelli S; Rapizzi E; Luconi M; Maggi M; Mannelli M; Ercolino T; Canu L
Medicina (Kaunas); 2022 Aug; 58(8):. PubMed ID: 36013579
[TBL] [Abstract][Full Text] [Related]
3. Whole Exome Sequencing Uncovers Germline Variants of Cancer-Related Genes in Sporadic Pheochromocytoma.
Urbini M; Nannini M; Astolfi A; Indio V; Vicennati V; De Luca M; Tarantino G; Corso F; Saponara M; Gatto L; Santini D; Di Dalmazi G; Pagotto U; Pasquali R; Pession A; Biasco G; Pantaleo MA
Int J Genomics; 2018; 2018():6582014. PubMed ID: 30211214
[TBL] [Abstract][Full Text] [Related]
4. Emerging role of dopamine in neovascularization of pheochromocytoma and paraganglioma.
Osinga TE; Links TP; Dullaart RPF; Pacak K; van der Horst-Schrivers ANA; Kerstens MN; Kema IP
FASEB J; 2017 Jun; 31(6):2226-2240. PubMed ID: 28264974
[TBL] [Abstract][Full Text] [Related]
5. Molecular markers of paragangliomas/pheochromocytomas.
Zhikrivetskaya SO; Snezhkina AV; Zaretsky AR; Alekseev BY; Pokrovsky AV; Golovyuk AL; Melnikova NV; Stepanov OA; Kalinin DV; Moskalev AA; Krasnov GS; Dmitriev AA; Kudryavtseva AV
Oncotarget; 2017 Apr; 8(15):25756-25782. PubMed ID: 28187001
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma.
Fishbein L; Leshchiner I; Walter V; Danilova L; Robertson AG; Johnson AR; Lichtenberg TM; Murray BA; Ghayee HK; Else T; Ling S; Jefferys SR; de Cubas AA; Wenz B; Korpershoek E; Amelio AL; Makowski L; Rathmell WK; Gimenez-Roqueplo AP; Giordano TJ; Asa SL; Tischler AS; ; Pacak K; Nathanson KL; Wilkerson MD
Cancer Cell; 2017 Feb; 31(2):181-193. PubMed ID: 28162975
[TBL] [Abstract][Full Text] [Related]
7. The Roles of PI3K/AKT/mTOR and MAPK/ERK Signaling Pathways in Human Pheochromocytomas.
Du J; Tong A; Wang F; Cui Y; Li C; Zhang Y; Yan Z
Int J Endocrinol; 2016; 2016():5286972. PubMed ID: 27990160
[No Abstract] [Full Text] [Related]
8. Pheochromocytoma: Gasping for Air.
Jochmanová I; Zhuang Z; Pacak K
Horm Cancer; 2015 Dec; 6(5-6):191-205. PubMed ID: 26138106
[TBL] [Abstract][Full Text] [Related]
9. Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas.
Fishbein L; Khare S; Wubbenhorst B; DeSloover D; D'Andrea K; Merrill S; Cho NW; Greenberg RA; Else T; Montone K; LiVolsi V; Fraker D; Daber R; Cohen DL; Nathanson KL
Nat Commun; 2015 Jan; 6():6140. PubMed ID: 25608029
[TBL] [Abstract][Full Text] [Related]
10. Anti-cancer potential of MAPK pathway inhibition in paragangliomas-effect of different statins on mouse pheochromocytoma cells.
Fliedner SM; Engel T; Lendvai NK; Shankavaram U; Nölting S; Wesley R; Elkahloun AG; Ungefroren H; Oldoerp A; Lampert G; Lehnert H; Timmers H; Pacak K
PLoS One; 2014; 9(5):e97712. PubMed ID: 24846270
[TBL] [Abstract][Full Text] [Related]
11. Secondary malignancy in patients with sporadic neuroendocrine neoplasia.
Krausch M; Raffel A; Anlauf M; Schott M; Lehwald N; Krieg A; Kröpil F; Cupisti K; Knoefel WT
Endocrine; 2013 Oct; 44(2):510-6. PubMed ID: 23494366
[TBL] [Abstract][Full Text] [Related]
12. Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background.
Fishbein L; Nathanson KL
Cancer Genet; 2012; 205(1-2):1-11. PubMed ID: 22429592
[TBL] [Abstract][Full Text] [Related]
13. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas.
Benn DE; Croxson MS; Tucker K; Bambach CP; Richardson AL; Delbridge L; Pullan PT; Hammond J; Marsh DJ; Robinson BG
Oncogene; 2003 Mar; 22(9):1358-64. PubMed ID: 12618761
[TBL] [Abstract][Full Text] [Related]
14. Molecular genetics of malignant insulinoma.
Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
[TBL] [Abstract][Full Text] [Related]
15. Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas.
Gimenez-Roqueplo AP; Favier J; Rustin P; Rieubland C; Crespin M; Nau V; Khau Van Kien P; Corvol P; Plouin PF; Jeunemaitre X;
Cancer Res; 2003 Sep; 63(17):5615-21. PubMed ID: 14500403
[TBL] [Abstract][Full Text] [Related]
16. Genetics and biology of pheochromocytoma.
Mannelli M; Simi L; Gaglianò MS; Opocher G; Ercolino T; Becherini L; Parenti G
Exp Clin Endocrinol Diabetes; 2007 Mar; 115(3):160-5. PubMed ID: 17427103
[TBL] [Abstract][Full Text] [Related]
17. Phaeochromocytoma in children.
Armstrong R; Sridhar M; Greenhalgh KL; Howell L; Jones C; Landes C; McPartland JL; Moores C; Losty PD; Didi M
Arch Dis Child; 2008 Oct; 93(10):899-904. PubMed ID: 18499773
[TBL] [Abstract][Full Text] [Related]
18. Analysis of selected genes in neuroendocrine tumours: insulinomas and phaeochromocytomas.
Hrasćan R; Pećina-Slaus N; Martić TN; Colić JF; Gall-Troselj K; Pavelić K; Karapandza N
J Neuroendocrinol; 2008 Aug; 20(8):1015-22. PubMed ID: 18510707
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]